Hospital Partnerships Target large hospitals and academic medical centers with established ECMO programs to pilot and adopt Breethe's compact artificial lung. Leverage founder credibility to open discussions with thoracic surgery and critical care teams, especially on the East Coast.

Lean Operations With a small team, pursue external partners for contract manufacturing, regulatory affairs, clinical trial management, and distribution to accelerate scale and market reach.

Regulatory Pathways Prioritize regulatory strategy and reimbursement planning to shorten time to market and influence hospital procurement decisions, identifying potential FDA clearance and payer engagement pathways.

Funding & Partnerships Leverage current funding to form co-development or distribution partnerships with established medical device companies that can help scale manufacturing, sales, and post-market support.

Market Need Position the compact ECMO as a transformative solution for lung failure, using clinical outcomes and quality of life improvements to drive hospital adoption and payer interest.